Observational and cost analysis of the implementation of breast cancer sentinel node intraoperative molecular diagnosis

Journal of Clinical Pathology

Volumn 63, Issue 6, 2010, Pages 522-529

  Cutress, R I ^a,c   McDowell, A ^a   Gabriel, F G ^a   Gill, J ^a   Jeffrey, M J ^a   Agrawal, A ^a   Wise, M ^a   Raftery, J ^b   Cree, Ian A ^a,b   Yiangou, C ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MAMMAGLOBIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HISTOLOGY; HISTOPATHOLOGY; HOSPITAL CARE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COSTS AND COST ANALYSIS; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH CARE COSTS; HUMANS; INTRAOPERATIVE CARE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

EID: 77953716392     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.072942     Document Type: Article

References (25)

1. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
2. MacNeill F. New start: the UK SLNB training programme - a progress report. Ann R Coll Surg Engl 2007;89(Suppl l):60-1.
3. van der Ploeg IM, Nieweg OE, van Rijk MC, et al. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34:1277-84.
4. Forrest AP, Everington D, McDonald CC, et al. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 1995;82:1504-8.
5. Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319-25.
6. The Association of Breast Surgery at BASO RCoSoE. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 2005;31:S1-21.
7. Tew K, Irwig L, Matthews A, et al. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 2005;92:1068-80.
8. Creager AJ, Geisinger KR. Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies. Adv Anat Pathol 2002;9:233-43.
9. Krishnamurthy S, Meric-Bernstam F, Lucci A, et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 2009;115:1555-62.
10. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008;122:2562-7.
11. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-16.
12. Mansel RE, Goyal A, Douglas-Jones A, et al. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time genesearch BLN assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat 2009;115: 595-600.
13. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 2008;26:3338-45.
14. Blumencranz P, Whitworth PW, Deck K, et al. Scientific impact recognition award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 2007;194:426-32.
15. Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 2008;247:136-42.
16. Martinez MD, Veys I, Majjaj S, et al. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol 2009;35:387-92.
17. Jeruss JS, Hunt KK, Xing Y, et al. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer 2006;107: 2328-36.
18. Veys I, Durbecq V, Majjaj S, et al. Eighteen months clinical experience with the GeneSearch breast lymph node assay. Am J Surg 2009;182:203-9.
19. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005;103:358-67.
20. Cserni G, Bianchi S, Vezzosi V, et al. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 2008;44:2185-91.
21. Verkooijen HM, Peterse JL, Schipper ME, et al. Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions. Eur J Cancer 2003;39:2187-91.
22. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International breast cancer study group. Lancet 1999;354:896-900.
23. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 2008;26:258-63.
24. Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Brit J Surg 2004;91:1245-52.
25. Yiangou C, Shousha S, Sinnett HD. Primary tumour characteristics and axillary lymph node status in breast cancer. Brit J Cancer 1999;80:1974-8.